Clinical Trials Browser

INDUSTRY × Recurrence × alvocidib × Clear all

NCT03969420 2023-11-09

Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy

Phase 2 Terminated

11 enrolled 10 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute